Kementec Solutions A/S: Financial statements 2023
CVR: 25806735
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Kementec Solutions A/S (CVR 25806735) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 21,124,583 and a net result of DKK 5,093,963 compared with DKK 5,393,508 the year before. That is a decrease of 0.1% compared with the year before. Equity in the 2023 report amounted to DKK 21,531,983. The solvency ratio was 68.7%. The company had 21 employees in the financial year.
- Gross Profit
- DKK 21,124,583
- Profit/Loss
- DKK 5,093,963
- Equity
- DKK 21,531,983
- Total Assets
- DKK 31,346,859
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 21.1 mio. | 5.1 mio. | 21.5 mio. | 21 |
| 2022 | - | 21.1 mio. | 5.4 mio. | 22.4 mio. | 20 |
| 2021 | - | 19.7 mio. | 5.2 mio. | 17 mio. | 18 |
| 2020 | - | 14.6 mio. | 1.7 mio. | 11.8 mio. | 18 |
| 2019 | - | 16.4 mio. | 4.1 mio. | 10.1 mio. | 19 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 1, 2023, Frank Vitzthum has joined the board of directors of Kementec Solutions A/S.
As of October 1, 2023, Christian Moraeno Dreher has left the board of directors of Kementec Solutions A/S.
As of September 1, 2023, Ute Salzbrenner has joined the board of directors of Kementec Solutions A/S.
As of August 31, 2023, Jochen Hirsch has left the board of directors of Kementec Solutions A/S.
Kementec Solutions A/S has published its annual report for 2022. Gross profit came to DKK 21,148,080, and the net result was DKK 5,393,508.
About Kementec Solutions A/S
Kementec Solutions A/S is a Danish company of the type Aktieselskab based in Taastrup, founded in 2000. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The company was previously named KEM-EN-TEC DIAGNOSTICS A/S. The management consists of Elaine Antonette Lundberg and Tobias Greve-Vilby. The board consists of Frank Vitzthum (chair), Christian Moraeno Dreher and Ute Salzbrenner. The company is owned by R-Biopharm AG. The company has 20 employees (2026). In 2025, the company reported a gross profit of DKK 18,706,173 and a net result of DKK 2,269,339 compared with DKK 1,565,137 the year before. Equity in the 2025 report amounted to DKK 25,366,459.